Hypercell Technologies Inc. funding

Hypercell Technologies Inc., a biotechnology company based in Ithaca, NY, filed a Form D with the SEC on October 14, 2026 and reported $3M raised of a $4.4M offering.

Amount raised$3M

Offering size$4.4M

Filed with the SECOctober 14, 2026

First saleSeptember 8, 2026

IndustryBiotechnology

SecuritiesEquity, Options or warrants, Security to be acquired on exercise

LocationIthaca, NY

FoundedMore than 5 years ago

Entity typeCorporation

Investors so far14

Minimum investment$1

Revenue rangeDecline to Disclose

View the original Form D on SEC EDGAR ↗ · All rounds filed Oct 14

Other health care rounds in New York

Swep Bio, Inc.$2.5M · Oct 29Biotechnology MOCEAN HOLDINGS Corp$1.5M · Oct 27Other Health Care Chickadee Biomedicines, Inc.$1M · Nov 10Biotechnology NBO Pharma Inc.$238K · Nov 9Pharmaceuticals